glp 1 eye disease Do GLP-1 Medications Cause Problems? Understanding the NAION Risk – Revolution Health & Wellness Doctor Explains GLP 1 Blindness
Description
Among GLP-1 users, the 18-month risk of ION was about 8.5 cases per 10,000 people, compared with 5.5 cases per 10,000 among patients taking SGLT2 inhibitors
Ill be watching this closely and doing a deeper dive on it very soon (Im in the process of writing the essay)
Actual medications may vary depending on the prescribing provider, pharmacy, and applicable regulations
Avoid carrying commercial quantities or unlabeled vials through international borders, as this can trigger additional screening and delays
In addition, Ozempic is approved specifically to treat Type 2 Diabetes and has shown the potential to lower Hemoglobin A1c by more than 2%
A trial showing 20% average weight loss means some people lost 30% and others lost 5%
